SKELAXIN

Post-LOE

metaxalone

Pfizer
NDAORALTABLET
Approved
Aug 1962
Lifecycle
Post-LOE
Competitive Pressure
35/100

Loss of Exclusivity

LOE Date
Feb 6, 2026
1 months ago
Patent Expiry
Feb 6, 2026

Patent Records (1)

Patent #ExpiryTypeUse Code
7122566
Feb 6, 2026Expired
U-915
Company
Pfizer
Pfizer
NEW YORK, NY
614 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers